Exact Mass: 508.2825
Exact Mass Matches: 508.2825
Found 171 metabolites which its exact mass value is equals to given mass value 508.2825
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
LysoPG(18:2(9Z,12Z)/0:0)
LysoPG(18:2(9Z,12Z)/0:0) is a lysophosphatidylglycerol. It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylglycerols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPG(18:2(9Z,12Z)/0:0), in particular, consists of one chain of linoleic acid at the C-1 position.
(3S,5R,6S,9R)-megastigman-3,9-diol 3-O-alpha-L-arabinofuranosyl-(1?6)-b-D-glucopyranoside
(2S,3aS)-5-(1-hydroxy-3-(4-methoxyphenyl)propylidene)-2-(2-hydroxypropan-2-yl)-3a,7-bis(3-methylbut-2-en-1-yl)tetrahydrobenzofuran-4,6(2H,5H)-dione|Flemiphilippinone A
(3S,5R,6S,9S)-megastigmane-3,9-diol 3-O-beta-D-(6-O-beta-D-apiofuranosyl)glucopyranoside|oblongionoside C
cyclo(N8-(alpha,alpha-dimethylallyl)-L-Trp-6a-(alpha,alpha-dimethylallyl)-L-Trp)
2,5-Piperazinedione, 3-[[1-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]methyl]-6-[[2-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]methyl]-, (3S,6S)_120157
C32H36N4O2_8a,16a-Bis(2-methyl-3-buten-2-yl)-5a,8,8a,13,13a,15a,16,16a-octahydroindolo[3,2:4,5]pyrrolo[1,2:4,5]pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-7,15(5H,7aH)-dione
(2E,4E)-1-[(2R,6S,14S,22S,25R)-25-(3,3-dimethyloxiran-2-yl)-15-methyl-1,3,13,15-tetraazaheptacyclo[18.4.1.0²,⁶.0⁶,²².0⁷,¹².0¹⁴,²².0¹⁶,²¹]pentacosa-7,9,11,16(21),17,19-hexaen-3-yl]hexa-2,4-dien-1-one
His Lys Pro Gln
His Lys Gln Pro
His Pro Lys Gln
His Pro Gln Lys
His Gln Lys Pro
His Gln Pro Lys
Ile Ile Thr Tyr
Ile Ile Tyr Thr
Ile Leu Thr Tyr
Ile Leu Tyr Thr
Ile Thr Ile Tyr
Ile Thr Leu Tyr
Ile Thr Tyr Ile
Ile Thr Tyr Leu
Ile Tyr Ile Thr
Ile Tyr Leu Thr
Ile Tyr Thr Ile
Ile Tyr Thr Leu
Lys His Pro Gln
Lys His Gln Pro
Lys Pro His Gln
Lys Pro Gln His
Lys Gln His Pro
Lys Gln Pro His
Leu Ile Thr Tyr
Leu Ile Tyr Thr
Leu Leu Thr Tyr
Leu Leu Tyr Thr
Leu Thr Ile Tyr
Leu Thr Leu Tyr
Leu Thr Tyr Ile
Leu Thr Tyr Leu
Leu Tyr Ile Thr
Leu Tyr Leu Thr
Leu Tyr Thr Ile
Leu Tyr Thr Leu
Pro His Lys Gln
Pro His Gln Lys
Pro Lys His Gln
Pro Lys Gln His
Pro Gln His Lys
Pro Gln Lys His
Gln His Lys Pro
Gln His Pro Lys
Gln Lys His Pro
Gln Lys Pro His
Gln Pro His Lys
Gln Pro Lys His
Thr Ile Ile Tyr
Thr Ile Leu Tyr
Thr Ile Tyr Ile
Thr Ile Tyr Leu
Thr Leu Ile Tyr
Thr Leu Leu Tyr
Thr Leu Tyr Ile
Thr Leu Tyr Leu
Thr Tyr Ile Ile
Thr Tyr Ile Leu
Thr Tyr Leu Ile
Thr Tyr Leu Leu
Tyr Ile Ile Thr
Tyr Ile Leu Thr
Tyr Ile Thr Ile
Tyr Ile Thr Leu
Tyr Leu Ile Thr
Tyr Leu Leu Thr
Tyr Leu Thr Ile
Tyr Leu Thr Leu
Tyr Thr Ile Ile
Tyr Thr Ile Leu
Tyr Thr Leu Ile
Tyr Thr Leu Leu
(5Z,7E)-(1S,3R)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3 / 26,26,26,27,27,27-hexafluoro-25-hydroxycholecalciferol
glas#20
An ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester resulting from the formal esterification of the carboxy group of ascr#20 with the anomeric hydroxy group of beta-D-glucopyranose. It is a metabolite of the nematode Caenorhabditis elegans.
26,26,26,27,27,27-hexafluoro-1alphaa-hydroxyvitamin D3
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3
1-O-{(11R)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodecanoyl}-beta-D-glucopyranose
2-(1,1-Dimethyl-2-propenyl)cyclo[L-Trp-2-(1,1-dimethyl-2-propenyl)-L-Trp-]
(3S)-3alpha-[1-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-6alpha-[2-(1,1-dimethyl-2-propenyl)-1H-indole-3-ylmethyl]piperazine-2,5-dione
1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-Hexadecanoyl-2-(5-hydroxypentanoyl)-sn-phosphatidate(2-)
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
1-(9Z,12Z-octadecadienoyl)-glycero-3-phospho-(1-sn-glycerol)
MCP110
MCP110 is an inhibitor of Ras/Raf-1 interaction. MCP110 blocks the interaction of Ras with Raf. MCP110 disrupts this interaction might can be used for the research of human tumors[1].